Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel target spot for treatment of pulmonary arterial hypertension

A technology for pulmonary arterial hypertension and new targets, applied in animal/human proteins, receptors/cell surface antigens/cell surface determinants, specific peptides, etc., can solve problems such as unclear mechanism of action and regulation

Inactive Publication Date: 2013-12-25
PEKING UNIV
View PDF4 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the mechanism and regulation of 5-HT2BR in PAH are still unclear

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel target spot for treatment of pulmonary arterial hypertension
  • Novel target spot for treatment of pulmonary arterial hypertension

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0014] figure 1 Increased expression of 5-HT2BR in rats with pulmonary arterial hypertension

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a novel target spot for the treatment of pulmonary arterial hypertension. The novel target spot for the treatment of pulmonary arterial hypertension aims at a serotonin 2B receptor (5-HT2BR); pulmonary arterial hypertension has a significant characteristic of high shrinkage in pulmonary artery; and inhibition on activity of the 5-HT2BR can significantly inhibit the systolic function of the pulmonary artery. The receptor can be used as a novel target spot for the treatment of pulmonary hypertension therapy.

Description

technical field [0001] The invention relates to five serotonin type 2B receptors (5-HT2BR) which play an important role in the process of pulmonary arterial hypertension by participating in the contraction of pulmonary arteries, thereby serving as a new target for treating pulmonary arterial hypertension. Background technique [0002] Pulmonary arterial hypertension (PAH) is a chronic disease characterized by pulmonary artery hyperconstriction and vascular remodeling accompanied by increased pulmonary artery pressure and right ventricular failure [1]. PAH has become a common disease that seriously threatens human physical and mental health. . In normal people, the pulmonary artery pressure is 12-16mmHg at rest, and when the pulmonary artery pressure is higher than 25mmHg, it is defined as pulmonary hypertension. The main symptoms of PAH include shortness of breath, dizziness and fainting, chest pain, etc. PAH is divided into primary and secondary. Secondary pulmonary hype...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K14/705
Inventor 汪南平刘雅涵赵蓓蕾
Owner PEKING UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products